OW 2025 4 - 7 November 2025

STEP UP: efficacy of semaglutide in obesity treatment targets and cardiovascular risk thresholds

Authors :

Carel W le Roux^1,2; W. Timothy Garvey³; Kristoffer Jensen Kolnes⁴; Jøran Hjelmesæth⁵; Ildiko Lingvay⁶; Niklas Kahr Rasmussen⁴; Volker Schnecke⁴; Luca Busetto⁷

Affiliations

View Details Hide Details

Download infographic (.pdf)

Keywords

Obesity

Congress oral presentation

GLP-1 RA

Semaglutide

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

STEP UP: efficacy of semaglutide in obesity treatment targets and cardiovascular risk thresholds